ARCT: Arcturus Therapeutics Holdings Inc

FinancialsDividends

$12.67

-0.39

(-2.99%)

As of 07/30/2025 5:00 PM ET • Disclaimer
Powered by Stocksift.com

100%

ARCT Performance Snapshot

1-Week Chg

-17.99%

1-Month Chg

-2.61%

3-Month Chg

-1.09%

6-Month Chg

-27.27%

1-Year Chg

-45.74%

Year-To-Date Chg

-25.78%

Beta 1-Year

2.35

Beta 5-Year

3.11

Volatility (10-Day)

6.11%

ARCT Technical Snapshot

Datesorted descending
Close
Change 1D
Open
High
Low
Typical
Volume

2025-07-30

$12.67

-$0.39 (-2.99%)

$13.29

$13.56

$12.57

$12.94

507.00K ($6.42M)

2025-07-29

$13.06

-$1.32 (-9.18%)

$14.31

$14.34

$12.60

$13.33

678.00K ($8.85M)

2025-07-28

$14.38

-$0.56 (-3.75%)

$14.93

$15.18

$14.24

$14.60

338.00K ($4.86M)

2025-07-25

$14.94

-$0.01 (-0.07%)

$14.98

$15.25

$14.48

$14.89

327.00K ($4.89M)

2025-07-24

$14.95

-$0.50 (-3.24%)

$15.37

$15.50

$14.78

$15.08

252.00K ($3.77M)

2025-07-23

$15.45

$0.92 (6.33%)

$14.84

$15.83

$14.61

$15.30

423.00K ($6.54M)

2025-07-22

$14.53

$0.74 (5.37%)

$13.83

$14.62

$13.83

$14.33

289.00K ($4.20M)

2025-07-21

$13.79

$0.29 (2.15%)

$13.59

$14.19

$13.59

$13.86

262.00K ($3.61M)

2025-07-18

$13.50

-$0.04 (-0.3%)

$13.73

$14.02

$13.49

$13.67

279.00K ($3.77M)

2025-07-17

$13.54

$0.69 (5.37%)

$12.87

$13.85

$12.79

$13.39

397.00K ($5.38M)

ARCT Financial Snapshot

Balance Sheet

(USD)

2025 Q1

Y/Y CHANGE

  • Cash and equivalents

    $255.45M

    -25.61%

  • Total assets

    $331.79M

    -20.79%

  • Total liabilities

    $98.03M

    -36.71%

  • Total investments

    $18.39M

    875.33%

  • Shareholders' equity

    $233.76M

    -11.45%

  • Book value per share

    $8.62

    -12.19%

Income Statement

(USD)

2025 Q1

Y/Y CHANGE

  • Revenue

    $29.38M

    -22.70%

  • Net income

    -$14.08M

    47.51%

  • Operating expense

    $46.21M

    -32.47%

  • Gross profit

    $29.38M

    -22.70%

  • EBITDA

    -$13.28M

    48.03%

  • Earnings per share

    -$0.52

    48.00%

Cash Flow

(USD)

2025 Q1

Y/Y CHANGE

  • Net change in cash

    -$20.08M

    -456.39%

  • Cash from operations

    -$35.14M

    -532.32%

  • Cash from investing

    -$137.00K

    42.92%

  • Cash from financing

    $15.20M

    594.47%

  • Free cash flow

    -$35.27M

    -508.50%

  • Free cash flow per share

    -$1.30

    -502.31%

Metrics

(USD)

2025 Q1

Y/Y CHANGE

  • Market capitalization

    $287.20M

    -68.40%

  • Enterprise value

    $20.17M

    -96.57%

  • Shares outstanding

    27.12M

    0.76%

  • Profit margin

    -47.90%

    32.06%

  • Gross margin

    100.00%

    0%

  • EBITDA margin

    -45.20%

    32.74%

Dividends

(USD)

2025 Q1

Y/Y CHANGE

  • Dividend yield

    0%

    0%

  • Dividends per share

    $0

    0%

  • Dividend growth

    -

    -

  • Payout ratio

    0%

    0%

  • Coverage ratio

    -

    -

  • Current ratio

    5.64

    73.31%

View Financial Statements